jueves, 13 de septiembre de 2012

Esto es crisis(III)...: Pharmaceutical research and development: what do we get for all that money?


The true crisis in pharmaceutical research

  • The number of new drugs licensed remains at the long term average range of 15-25 a year
  • However, 85-90% of new products over the past 50 years have provided few benefits and considerable harms
  • The pharmaceutical industry devotes most research funds to developing scores of minor variations that produce a steady stream of profits
  • Heavy promotion of these drugs contributes to overuse and accounts for as much as 80% of a nation’s increase in drug expenditure
  • Overinflated estimates of the average cost of research and development are used to lobby for more protection from free market competition
Ver

Ver anterior:

Esto es crisis (II)...: Pharmaceutical research and development: what do we get for all that money?

Publicar un comentario